An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers

NCT01466335 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Bone Marrow Transplantation

Interventions

DRUG: Ronacaleret (100mg tablet)
DRUG: Placebo

Sponsor

GlaxoSmithKline